Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Medical Devices

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Great themes in news release - beautiful

<< Previous

Bullboard Posts

Next >>

Comment by PingPong888on May 11, 2020 9:15am

64 Views

Post# 31011070

RE:RE:Great themes in news release - beautiful

PingPong888 wrote:
PingPong888 wrote: It is only logical that AmnioBoost will show promise in treatment of COVID-19 associated lung disease, said Kenneth R. Conger, MD, Medical Director for Lattice Biologics Ltd.

To date, the Company continues to enroll patients in Montana and is in negotiations with contract research organizations (CROs) to facilitate patient recruitment

Additional studies are expected to take place outside the U.S.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal